Growth Metrics

NovaBridge Biosciences (NBP) Assets Average (2020 - 2025)

NovaBridge Biosciences (NBP) reported Assets Average of $269.0 million for Q4 2025, up 20.79% year-over-year from $222.7 million in Q4 2024, and up 11.12% on a QoQ basis from $242.1 million in Q3 2025.

NovaBridge Biosciences (NBP) has 6 years of Assets Average data on file, last reported at $269.0 million in Q4 2025.

  • Quarterly Assets Average rose 20.79% year-over-year to $269.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $269.0 million (up 20.79% YoY) and the FY2025 annual result came in at $236.6 million, down 18.66% from the prior year.
  • Assets Average advanced to $269.0 million in Q4 2025 per NBP's latest filing, from $242.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $954.0 million in Q2 2021 and bottomed at $207.8 million in Q2 2025.
  • The 5-year median for Assets Average is $269.0 million (2025), against an average of $478.4 million.
  • The widest annual swing landed in 2021, when Assets Average jumped 255.62%; it then tumbled 34.8% in 2023.
  • Tracing NBP's Assets Average over 5 years: stood at $914.1 million in 2021, then declined by 27.91% to $659.0 million in 2022, then fell by 19.8% to $528.5 million in 2023, then tumbled by 57.87% to $222.7 million in 2024, then advanced by 20.79% to $269.0 million in 2025.
  • Per Business Quant, the three latest NBP Assets Average figures stand at $269.0 million (Q4 2025), $242.1 million (Q3 2025), and $207.8 million (Q2 2025).

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 268.97 Mn
Sep 30, 2025 242.06 Mn
Jun 30, 2025 207.82 Mn
Mar 31, 2025 210.81 Mn
Dec 31, 2024 222.68 Mn
Sep 30, 2024 243.25 Mn
Jun 30, 2023 528.53 Mn
Dec 31, 2022 659.00 Mn
Jun 30, 2022 810.65 Mn
Dec 31, 2021 914.14 Mn
Jun 30, 2021 953.97 Mn
Dec 31, 2020 794.38 Mn
Sep 30, 2020 461.51 Mn
Jun 30, 2020 268.25 Mn